220 related articles for article (PubMed ID: 29888478)
1. Baclofen for alcohol use disorder-a systematic meta-analysis.
Bschor T; Henssler J; Müller M; Baethge C
Acta Psychiatr Scand; 2018 Sep; 138(3):232-242. PubMed ID: 29888478
[TBL] [Abstract][Full Text] [Related]
2. Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis.
Rose AK; Jones A
Addiction; 2018 Aug; 113(8):1396-1406. PubMed ID: 29479827
[TBL] [Abstract][Full Text] [Related]
3. A human laboratory pilot study with baclofen in alcoholic individuals.
Leggio L; Zywiak WH; McGeary JE; Edwards S; Fricchione SR; Shoaff JR; Addolorato G; Swift RM; Kenna GA
Pharmacol Biochem Behav; 2013 Feb; 103(4):784-91. PubMed ID: 23262301
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: A systematic review and meta-analysis.
Pierce M; Sutterland A; Beraha EM; Morley K; van den Brink W
Eur Neuropsychopharmacol; 2018 Jul; 28(7):795-806. PubMed ID: 29934090
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.
Palpacuer C; Duprez R; Huneau A; Locher C; Boussageon R; Laviolle B; Naudet F
Addiction; 2018 Feb; 113(2):220-237. PubMed ID: 28940866
[TBL] [Abstract][Full Text] [Related]
6. Baclofen as add-on to standard psychosocial treatment for alcohol dependence: a randomized, double-blind, placebo-controlled trial with 1 year follow-up.
Ponizovsky AM; Rosca P; Aronovich E; Weizman A; Grinshpoon A
J Subst Abuse Treat; 2015 May; 52():24-30. PubMed ID: 25572706
[TBL] [Abstract][Full Text] [Related]
7. Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial.
Addolorato G; Leggio L; Ferrulli A; Cardone S; Bedogni G; Caputo F; Gasbarrini G; Landolfi R;
Alcohol Alcohol; 2011; 46(3):312-7. PubMed ID: 21414953
[TBL] [Abstract][Full Text] [Related]
8. [Double blind placebo controlled randomized pilot clinical trial of baclofen (Baclosan®) for alcohol dependence].
Krupitsky EM; Rybakova KV; Kiselev AS; Alexeeva YV; Berntsev VA; Chekhlaty EI; Zubova EY; Popov YV; Neznanov NG
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):53-62. PubMed ID: 26356398
[TBL] [Abstract][Full Text] [Related]
9. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.
Hauser P; Fuller B; Ho SB; Thuras P; Kern S; Dieperink E
Addiction; 2017 Jul; 112(7):1173-1183. PubMed ID: 28192622
[TBL] [Abstract][Full Text] [Related]
10. Moderation of baclofen response by a GABA
Morley KC; Luquin N; Baillie A; Fraser I; Trent RJ; Dore G; Phung N; Haber PS
Addiction; 2018 Dec; 113(12):2205-2213. PubMed ID: 29968397
[TBL] [Abstract][Full Text] [Related]
11. A Randomized, Placebo-Controlled Study of High-Dose Baclofen in Alcohol-Dependent Patients-The ALPADIR Study.
Reynaud M; Aubin HJ; Trinquet F; Zakine B; Dano C; Dematteis M; Trojak B; Paille F; Detilleux M
Alcohol Alcohol; 2017 Jul; 52(4):439-446. PubMed ID: 28525555
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial.
Garbutt JC; Kampov-Polevoy AB; Gallop R; Kalka-Juhl L; Flannery BA
Alcohol Clin Exp Res; 2010 Nov; 34(11):1849-57. PubMed ID: 20662805
[TBL] [Abstract][Full Text] [Related]
13. Baclofen for the Treatment of Alcohol Dependence and Possible Role of Comorbid Anxiety.
Morley KC; Baillie A; Leung S; Addolorato G; Leggio L; Haber PS
Alcohol Alcohol; 2014 Nov; 49(6):654-60. PubMed ID: 25246489
[TBL] [Abstract][Full Text] [Related]
14. [The efficacy of baclofen in alcohol dependence].
Neven A; Dumont GJH
Tijdschr Psychiatr; 2019; 61(8):544-553. PubMed ID: 31512738
[TBL] [Abstract][Full Text] [Related]
15. Baclofen and severe alcohol dependence: an uncertain harm-benefit balance as of early 2013.
Prescrire Int; 2013 Sep; 22(141):214-7. PubMed ID: 24171218
[TBL] [Abstract][Full Text] [Related]
16. High-dose baclofen for treatment-resistant alcohol dependence.
Pastor A; Jones DM; Currie J
J Clin Psychopharmacol; 2012 Apr; 32(2):266-8. PubMed ID: 22367662
[TBL] [Abstract][Full Text] [Related]
17. Defining the role of baclofen for the treatment of alcohol dependence: a systematic review of the evidence.
Muzyk AJ; Rivelli SK; Gagliardi JP
CNS Drugs; 2012 Jan; 26(1):69-78. PubMed ID: 22145707
[TBL] [Abstract][Full Text] [Related]
18. Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection.
Leggio L; Ferrulli A; Zambon A; Caputo F; Kenna GA; Swift RM; Addolorato G
Addict Behav; 2012 Apr; 37(4):561-4. PubMed ID: 22244707
[TBL] [Abstract][Full Text] [Related]
19. High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial.
Müller CA; Geisel O; Pelz P; Higl V; Krüger J; Stickel A; Beck A; Wernecke KD; Hellweg R; Heinz A
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1167-77. PubMed ID: 26048580
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): study protocol for a randomised controlled trial.
Morley KC; Leung S; Baillie A; Haber PS
Contemp Clin Trials; 2013 Nov; 36(2):348-55. PubMed ID: 23939511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]